Literature DB >> 11440968

Fas/APO-1 promoter polymorphism is not associated with non-melanoma skin cancer.

H H Nelson1, K T Kelsey, M H Bronson, L A Mott, M R Karagas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11440968

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  3 in total

1.  Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.

Authors:  Tao Liu; Li Zuo; Lin Li; Lei Yin; Kai Liang; Hongyuan Yu; Hui Ren; Wen Zhou; Hongwei Jing; Yang Liu; Chuize Kong
Journal:  Tumour Biol       Date:  2014-08-02

2.  Polymorphisms of FAS and FAS ligand genes and risk of skin cancer.

Authors:  Abrar Qureshi; Hongmei Nan; Michael Dyer; Jiali Han
Journal:  J Dermatol Sci       Date:  2010-01-25       Impact factor: 4.563

Review 3.  Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.

Authors:  Yeqiong Xu; Bangshun He; Rui Li; Yuqin Pan; Tianyi Gao; Qiwen Deng; Huiling Sun; Guoqi Song; Shukui Wang
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.